Caboral, Madelene .
HRN: 26-46-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2025
CEFUROXIME 500MG (TAB)
05/01/2025
05/08/2025
PO
500mg
Bid
S/P Completion Curettage
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes